nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—PTGS1—kidney cancer	0.323	1	CbGaD
Zileuton—EPHX2—Sorafenib—kidney cancer	0.273	0.542	CbGbCtD
Zileuton—UGT1A9—Sorafenib—kidney cancer	0.0575	0.114	CbGbCtD
Zileuton—CYP3A4—Everolimus—kidney cancer	0.0271	0.054	CbGbCtD
Zileuton—CYP1A2—Pazopanib—kidney cancer	0.0184	0.0366	CbGbCtD
Zileuton—CYP3A4—Temsirolimus—kidney cancer	0.0183	0.0365	CbGbCtD
Zileuton—CYP2C9—Capecitabine—kidney cancer	0.0173	0.0344	CbGbCtD
Zileuton—CYP1A2—Erlotinib—kidney cancer	0.0131	0.0261	CbGbCtD
Zileuton—CYP2C9—Paclitaxel—kidney cancer	0.0108	0.0215	CbGbCtD
Zileuton—CYP1A2—Sorafenib—kidney cancer	0.0107	0.0212	CbGbCtD
Zileuton—CYP3A4—Pazopanib—kidney cancer	0.00963	0.0192	CbGbCtD
Zileuton—CYP2C9—Sorafenib—kidney cancer	0.00961	0.0191	CbGbCtD
Zileuton—CYP3A4—Erlotinib—kidney cancer	0.00687	0.0137	CbGbCtD
Zileuton—CYP3A4—Paclitaxel—kidney cancer	0.00629	0.0125	CbGbCtD
Zileuton—CYP3A4—Sorafenib—kidney cancer	0.00559	0.0111	CbGbCtD
Zileuton—CYP3A4—Vinblastine—kidney cancer	0.00552	0.011	CbGbCtD
Zileuton—CYP3A4—Vincristine—kidney cancer	0.00542	0.0108	CbGbCtD
Zileuton—CYP3A4—Sunitinib—kidney cancer	0.00453	0.009	CbGbCtD
Zileuton—CYP3A4—Doxorubicin—kidney cancer	0.00339	0.00674	CbGbCtD
Zileuton—CYP1A2—urine—kidney cancer	0.0014	0.138	CbGeAlD
Zileuton—EPHX2—nephron tubule—kidney cancer	0.00136	0.134	CbGeAlD
Zileuton—CYP2C9—urine—kidney cancer	0.00133	0.131	CbGeAlD
Zileuton—Tiaprofenic acid—PTGS1—kidney cancer	0.00119	0.636	CrCbGaD
Zileuton—EPHX2—cortex of kidney—kidney cancer	0.00116	0.114	CbGeAlD
Zileuton—UGT1A9—renal system—kidney cancer	0.00113	0.111	CbGeAlD
Zileuton—UGT1A9—kidney—kidney cancer	0.00109	0.107	CbGeAlD
Zileuton—CYP3A4—urine—kidney cancer	0.00101	0.0997	CbGeAlD
Zileuton—Tiaprofenic acid—PTGS2—kidney cancer	0.000678	0.364	CrCbGaD
Zileuton—CYP1A2—renal system—kidney cancer	0.000343	0.0337	CbGeAlD
Zileuton—Hypersensitivity—Temsirolimus—kidney cancer	0.000333	0.00317	CcSEcCtD
Zileuton—Liver injury—Doxorubicin—kidney cancer	0.000333	0.00317	CcSEcCtD
Zileuton—Pruritus—Temsirolimus—kidney cancer	0.00032	0.00305	CcSEcCtD
Zileuton—Diarrhoea—Temsirolimus—kidney cancer	0.000309	0.00295	CcSEcCtD
Zileuton—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000308	0.00294	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Doxorubicin—kidney cancer	0.000308	0.00293	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000306	0.00292	CcSEcCtD
Zileuton—Arthralgia—Sorafenib—kidney cancer	0.000305	0.0029	CcSEcCtD
Zileuton—Myalgia—Sorafenib—kidney cancer	0.000305	0.0029	CcSEcCtD
Zileuton—Insomnia—Everolimus—kidney cancer	0.000304	0.0029	CcSEcCtD
Zileuton—Ill-defined disorder—Dactinomycin—kidney cancer	0.000302	0.00288	CcSEcCtD
Zileuton—Pruritus—Pazopanib—kidney cancer	0.000301	0.00287	CcSEcCtD
Zileuton—Somnolence—Everolimus—kidney cancer	0.000299	0.00285	CcSEcCtD
Zileuton—Dizziness—Temsirolimus—kidney cancer	0.000299	0.00285	CcSEcCtD
Zileuton—PTGS1—renal system—kidney cancer	0.000297	0.0292	CbGeAlD
Zileuton—Dyspepsia—Everolimus—kidney cancer	0.000296	0.00282	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000296	0.00281	CcSEcCtD
Zileuton—Malaise—Dactinomycin—kidney cancer	0.000294	0.0028	CcSEcCtD
Zileuton—Insomnia—Erlotinib—kidney cancer	0.000294	0.00279	CcSEcCtD
Zileuton—Arthralgia—Sunitinib—kidney cancer	0.000293	0.00279	CcSEcCtD
Zileuton—Myalgia—Sunitinib—kidney cancer	0.000293	0.00279	CcSEcCtD
Zileuton—Chest pain—Sunitinib—kidney cancer	0.000293	0.00279	CcSEcCtD
Zileuton—Diarrhoea—Pazopanib—kidney cancer	0.000291	0.00277	CcSEcCtD
Zileuton—Gastrointestinal disorder—Everolimus—kidney cancer	0.00029	0.00276	CcSEcCtD
Zileuton—Constipation—Vinblastine—kidney cancer	0.000289	0.00275	CcSEcCtD
Zileuton—Pain—Vinblastine—kidney cancer	0.000289	0.00275	CcSEcCtD
Zileuton—Abdominal pain upper—Capecitabine—kidney cancer	0.000288	0.00274	CcSEcCtD
Zileuton—Conjunctivitis—Paclitaxel—kidney cancer	0.000288	0.00274	CcSEcCtD
Zileuton—Urinary tract infection—Paclitaxel—kidney cancer	0.000288	0.00274	CcSEcCtD
Zileuton—Constipation—Everolimus—kidney cancer	0.000288	0.00274	CcSEcCtD
Zileuton—Pain—Everolimus—kidney cancer	0.000288	0.00274	CcSEcCtD
Zileuton—Vomiting—Temsirolimus—kidney cancer	0.000288	0.00274	CcSEcCtD
Zileuton—PTGS1—kidney—kidney cancer	0.000287	0.0282	CbGeAlD
Zileuton—Dyspepsia—Erlotinib—kidney cancer	0.000286	0.00272	CcSEcCtD
Zileuton—Rash—Temsirolimus—kidney cancer	0.000285	0.00271	CcSEcCtD
Zileuton—Dermatitis—Temsirolimus—kidney cancer	0.000285	0.00271	CcSEcCtD
Zileuton—Headache—Temsirolimus—kidney cancer	0.000283	0.0027	CcSEcCtD
Zileuton—Neck pain—Doxorubicin—kidney cancer	0.000283	0.0027	CcSEcCtD
Zileuton—Dizziness—Pazopanib—kidney cancer	0.000282	0.00268	CcSEcCtD
Zileuton—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00028	0.00267	CcSEcCtD
Zileuton—Vaginal inflammation—Doxorubicin—kidney cancer	0.00028	0.00266	CcSEcCtD
Zileuton—Feeling abnormal—Vinblastine—kidney cancer	0.000278	0.00265	CcSEcCtD
Zileuton—Sinusitis—Paclitaxel—kidney cancer	0.000278	0.00264	CcSEcCtD
Zileuton—Constipation—Erlotinib—kidney cancer	0.000278	0.00264	CcSEcCtD
Zileuton—Pain—Erlotinib—kidney cancer	0.000278	0.00264	CcSEcCtD
Zileuton—Myalgia—Dactinomycin—kidney cancer	0.000277	0.00264	CcSEcCtD
Zileuton—Feeling abnormal—Everolimus—kidney cancer	0.000277	0.00264	CcSEcCtD
Zileuton—Discomfort—Dactinomycin—kidney cancer	0.000274	0.00261	CcSEcCtD
Zileuton—Vomiting—Pazopanib—kidney cancer	0.000271	0.00258	CcSEcCtD
Zileuton—Rash—Pazopanib—kidney cancer	0.000269	0.00256	CcSEcCtD
Zileuton—Nausea—Temsirolimus—kidney cancer	0.000269	0.00256	CcSEcCtD
Zileuton—Dermatitis—Pazopanib—kidney cancer	0.000268	0.00255	CcSEcCtD
Zileuton—Headache—Pazopanib—kidney cancer	0.000267	0.00254	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000266	0.00253	CcSEcCtD
Zileuton—PTGS1—cardiac atrium—kidney cancer	0.000266	0.0262	CbGeAlD
Zileuton—Body temperature increased—Everolimus—kidney cancer	0.000266	0.00253	CcSEcCtD
Zileuton—Vaginal infection—Doxorubicin—kidney cancer	0.000264	0.00252	CcSEcCtD
Zileuton—Dyspepsia—Sorafenib—kidney cancer	0.000257	0.00245	CcSEcCtD
Zileuton—Body temperature increased—Erlotinib—kidney cancer	0.000257	0.00244	CcSEcCtD
Zileuton—Ill-defined disorder—Gemcitabine—kidney cancer	0.000256	0.00244	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000256	0.00244	CcSEcCtD
Zileuton—Insomnia—Sunitinib—kidney cancer	0.000254	0.00242	CcSEcCtD
Zileuton—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000253	0.00241	CcSEcCtD
Zileuton—Nausea—Pazopanib—kidney cancer	0.000253	0.00241	CcSEcCtD
Zileuton—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000252	0.0024	CcSEcCtD
Zileuton—Constipation—Sorafenib—kidney cancer	0.00025	0.00238	CcSEcCtD
Zileuton—Pain—Sorafenib—kidney cancer	0.00025	0.00238	CcSEcCtD
Zileuton—Malaise—Gemcitabine—kidney cancer	0.000249	0.00237	CcSEcCtD
Zileuton—Hypersensitivity—Vinblastine—kidney cancer	0.000249	0.00237	CcSEcCtD
Zileuton—CYP3A4—renal system—kidney cancer	0.000248	0.0244	CbGeAlD
Zileuton—Myalgia—Vincristine—kidney cancer	0.000248	0.00236	CcSEcCtD
Zileuton—Hypersensitivity—Everolimus—kidney cancer	0.000248	0.00236	CcSEcCtD
Zileuton—Dyspepsia—Sunitinib—kidney cancer	0.000247	0.00235	CcSEcCtD
Zileuton—Hypertonia—Doxorubicin—kidney cancer	0.000245	0.00234	CcSEcCtD
Zileuton—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000243	0.00231	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000242	0.00231	CcSEcCtD
Zileuton—Constipation—Sunitinib—kidney cancer	0.00024	0.00229	CcSEcCtD
Zileuton—Pain—Sunitinib—kidney cancer	0.00024	0.00229	CcSEcCtD
Zileuton—CYP3A4—kidney—kidney cancer	0.00024	0.0236	CbGeAlD
Zileuton—Lymphadenopathy—Doxorubicin—kidney cancer	0.000238	0.00227	CcSEcCtD
Zileuton—Pruritus—Everolimus—kidney cancer	0.000238	0.00227	CcSEcCtD
Zileuton—Jaundice—Capecitabine—kidney cancer	0.000237	0.00225	CcSEcCtD
Zileuton—Conjunctivitis—Capecitabine—kidney cancer	0.000236	0.00225	CcSEcCtD
Zileuton—Urinary tract infection—Capecitabine—kidney cancer	0.000236	0.00225	CcSEcCtD
Zileuton—Chest pain—Gemcitabine—kidney cancer	0.000235	0.00224	CcSEcCtD
Zileuton—Myalgia—Gemcitabine—kidney cancer	0.000235	0.00224	CcSEcCtD
Zileuton—Arthralgia—Gemcitabine—kidney cancer	0.000235	0.00224	CcSEcCtD
Zileuton—Discomfort—Gemcitabine—kidney cancer	0.000232	0.00221	CcSEcCtD
Zileuton—Urticaria—Sorafenib—kidney cancer	0.000232	0.00221	CcSEcCtD
Zileuton—Diarrhoea—Vinblastine—kidney cancer	0.000231	0.0022	CcSEcCtD
Zileuton—Body temperature increased—Sorafenib—kidney cancer	0.000231	0.0022	CcSEcCtD
Zileuton—Diarrhoea—Everolimus—kidney cancer	0.00023	0.00219	CcSEcCtD
Zileuton—Pruritus—Erlotinib—kidney cancer	0.00023	0.00219	CcSEcCtD
Zileuton—Flatulence—Paclitaxel—kidney cancer	0.000228	0.00217	CcSEcCtD
Zileuton—Pain—Dactinomycin—kidney cancer	0.000227	0.00217	CcSEcCtD
Zileuton—Tension—Paclitaxel—kidney cancer	0.000227	0.00216	CcSEcCtD
Zileuton—Nervousness—Paclitaxel—kidney cancer	0.000225	0.00214	CcSEcCtD
Zileuton—Dizziness—Vinblastine—kidney cancer	0.000223	0.00213	CcSEcCtD
Zileuton—Dizziness—Everolimus—kidney cancer	0.000222	0.00212	CcSEcCtD
Zileuton—Body temperature increased—Sunitinib—kidney cancer	0.000222	0.00211	CcSEcCtD
Zileuton—Diarrhoea—Erlotinib—kidney cancer	0.000222	0.00211	CcSEcCtD
Zileuton—Feeling abnormal—Dactinomycin—kidney cancer	0.000219	0.00209	CcSEcCtD
Zileuton—Hepatitis—Capecitabine—kidney cancer	0.000218	0.00208	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000217	0.00206	CcSEcCtD
Zileuton—Hypersensitivity—Sorafenib—kidney cancer	0.000215	0.00205	CcSEcCtD
Zileuton—Insomnia—Vincristine—kidney cancer	0.000215	0.00205	CcSEcCtD
Zileuton—Vomiting—Vinblastine—kidney cancer	0.000215	0.00204	CcSEcCtD
Zileuton—Dizziness—Erlotinib—kidney cancer	0.000215	0.00204	CcSEcCtD
Zileuton—Ill-defined disorder—Paclitaxel—kidney cancer	0.000215	0.00204	CcSEcCtD
Zileuton—Vomiting—Everolimus—kidney cancer	0.000214	0.00204	CcSEcCtD
Zileuton—Rash—Everolimus—kidney cancer	0.000212	0.00202	CcSEcCtD
Zileuton—Dermatitis—Everolimus—kidney cancer	0.000212	0.00202	CcSEcCtD
Zileuton—Headache—Vinblastine—kidney cancer	0.000212	0.00201	CcSEcCtD
Zileuton—Headache—Everolimus—kidney cancer	0.000211	0.00201	CcSEcCtD
Zileuton—Body temperature increased—Dactinomycin—kidney cancer	0.00021	0.002	CcSEcCtD
Zileuton—Malaise—Paclitaxel—kidney cancer	0.000209	0.00199	CcSEcCtD
Zileuton—Hypersensitivity—Sunitinib—kidney cancer	0.000207	0.00197	CcSEcCtD
Zileuton—Pruritus—Sorafenib—kidney cancer	0.000207	0.00197	CcSEcCtD
Zileuton—Vomiting—Erlotinib—kidney cancer	0.000206	0.00196	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000205	0.00196	CcSEcCtD
Zileuton—Gastrointestinal disorder—Vincristine—kidney cancer	0.000205	0.00195	CcSEcCtD
Zileuton—Rash—Erlotinib—kidney cancer	0.000205	0.00195	CcSEcCtD
Zileuton—Dermatitis—Erlotinib—kidney cancer	0.000204	0.00195	CcSEcCtD
Zileuton—Insomnia—Gemcitabine—kidney cancer	0.000204	0.00194	CcSEcCtD
Zileuton—Headache—Erlotinib—kidney cancer	0.000203	0.00194	CcSEcCtD
Zileuton—Pain—Vincristine—kidney cancer	0.000203	0.00193	CcSEcCtD
Zileuton—Constipation—Vincristine—kidney cancer	0.000203	0.00193	CcSEcCtD
Zileuton—Nausea—Vinblastine—kidney cancer	0.000201	0.00191	CcSEcCtD
Zileuton—Somnolence—Gemcitabine—kidney cancer	0.0002	0.00191	CcSEcCtD
Zileuton—Nausea—Everolimus—kidney cancer	0.0002	0.0019	CcSEcCtD
Zileuton—Diarrhoea—Sorafenib—kidney cancer	0.0002	0.0019	CcSEcCtD
Zileuton—Pruritus—Sunitinib—kidney cancer	0.000199	0.00189	CcSEcCtD
Zileuton—Chest pain—Paclitaxel—kidney cancer	0.000197	0.00187	CcSEcCtD
Zileuton—Myalgia—Paclitaxel—kidney cancer	0.000197	0.00187	CcSEcCtD
Zileuton—Arthralgia—Paclitaxel—kidney cancer	0.000197	0.00187	CcSEcCtD
Zileuton—Hypersensitivity—Dactinomycin—kidney cancer	0.000196	0.00187	CcSEcCtD
Zileuton—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000195	0.00185	CcSEcCtD
Zileuton—Discomfort—Paclitaxel—kidney cancer	0.000195	0.00185	CcSEcCtD
Zileuton—Dizziness—Sorafenib—kidney cancer	0.000193	0.00184	CcSEcCtD
Zileuton—Constipation—Gemcitabine—kidney cancer	0.000193	0.00184	CcSEcCtD
Zileuton—Pain—Gemcitabine—kidney cancer	0.000193	0.00184	CcSEcCtD
Zileuton—Nausea—Erlotinib—kidney cancer	0.000193	0.00184	CcSEcCtD
Zileuton—Diarrhoea—Sunitinib—kidney cancer	0.000192	0.00183	CcSEcCtD
Zileuton—Body temperature increased—Vincristine—kidney cancer	0.000188	0.00179	CcSEcCtD
Zileuton—Flatulence—Capecitabine—kidney cancer	0.000187	0.00178	CcSEcCtD
Zileuton—Dizziness—Sunitinib—kidney cancer	0.000186	0.00177	CcSEcCtD
Zileuton—Feeling abnormal—Gemcitabine—kidney cancer	0.000186	0.00177	CcSEcCtD
Zileuton—Vomiting—Sorafenib—kidney cancer	0.000186	0.00177	CcSEcCtD
Zileuton—Abdominal pain upper—Doxorubicin—kidney cancer	0.000186	0.00177	CcSEcCtD
Zileuton—Rash—Sorafenib—kidney cancer	0.000184	0.00175	CcSEcCtD
Zileuton—Dermatitis—Sorafenib—kidney cancer	0.000184	0.00175	CcSEcCtD
Zileuton—Headache—Sorafenib—kidney cancer	0.000183	0.00174	CcSEcCtD
Zileuton—Diarrhoea—Dactinomycin—kidney cancer	0.000182	0.00173	CcSEcCtD
Zileuton—Vomiting—Sunitinib—kidney cancer	0.000179	0.0017	CcSEcCtD
Zileuton—Body temperature increased—Gemcitabine—kidney cancer	0.000178	0.0017	CcSEcCtD
Zileuton—Rash—Sunitinib—kidney cancer	0.000177	0.00169	CcSEcCtD
Zileuton—Dermatitis—Sunitinib—kidney cancer	0.000177	0.00168	CcSEcCtD
Zileuton—Ill-defined disorder—Capecitabine—kidney cancer	0.000176	0.00168	CcSEcCtD
Zileuton—Headache—Sunitinib—kidney cancer	0.000176	0.00168	CcSEcCtD
Zileuton—Hypersensitivity—Vincristine—kidney cancer	0.000175	0.00167	CcSEcCtD
Zileuton—Nausea—Sorafenib—kidney cancer	0.000173	0.00165	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000172	0.00164	CcSEcCtD
Zileuton—Malaise—Capecitabine—kidney cancer	0.000171	0.00163	CcSEcCtD
Zileuton—Insomnia—Paclitaxel—kidney cancer	0.000171	0.00163	CcSEcCtD
Zileuton—Vomiting—Dactinomycin—kidney cancer	0.000169	0.00161	CcSEcCtD
Zileuton—Somnolence—Paclitaxel—kidney cancer	0.000168	0.0016	CcSEcCtD
Zileuton—Rash—Dactinomycin—kidney cancer	0.000168	0.0016	CcSEcCtD
Zileuton—Nausea—Sunitinib—kidney cancer	0.000167	0.00159	CcSEcCtD
Zileuton—Dyspepsia—Paclitaxel—kidney cancer	0.000166	0.00158	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000163	0.00155	CcSEcCtD
Zileuton—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000163	0.00155	CcSEcCtD
Zileuton—Diarrhoea—Vincristine—kidney cancer	0.000163	0.00155	CcSEcCtD
Zileuton—Chest pain—Capecitabine—kidney cancer	0.000162	0.00154	CcSEcCtD
Zileuton—Arthralgia—Capecitabine—kidney cancer	0.000162	0.00154	CcSEcCtD
Zileuton—Myalgia—Capecitabine—kidney cancer	0.000162	0.00154	CcSEcCtD
Zileuton—Pain—Paclitaxel—kidney cancer	0.000161	0.00154	CcSEcCtD
Zileuton—Constipation—Paclitaxel—kidney cancer	0.000161	0.00154	CcSEcCtD
Zileuton—Discomfort—Capecitabine—kidney cancer	0.00016	0.00152	CcSEcCtD
Zileuton—Pruritus—Gemcitabine—kidney cancer	0.000159	0.00152	CcSEcCtD
Zileuton—Nausea—Dactinomycin—kidney cancer	0.000158	0.0015	CcSEcCtD
Zileuton—Dizziness—Vincristine—kidney cancer	0.000157	0.0015	CcSEcCtD
Zileuton—Feeling abnormal—Paclitaxel—kidney cancer	0.000156	0.00148	CcSEcCtD
Zileuton—Diarrhoea—Gemcitabine—kidney cancer	0.000154	0.00147	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—kidney cancer	0.000153	0.00145	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—kidney cancer	0.000152	0.00145	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—kidney cancer	0.000152	0.00145	CcSEcCtD
Zileuton—Vomiting—Vincristine—kidney cancer	0.000151	0.00144	CcSEcCtD
Zileuton—Urticaria—Paclitaxel—kidney cancer	0.00015	0.00143	CcSEcCtD
Zileuton—Rash—Vincristine—kidney cancer	0.00015	0.00143	CcSEcCtD
Zileuton—Dermatitis—Vincristine—kidney cancer	0.00015	0.00142	CcSEcCtD
Zileuton—Body temperature increased—Paclitaxel—kidney cancer	0.000149	0.00142	CcSEcCtD
Zileuton—Headache—Vincristine—kidney cancer	0.000149	0.00142	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—kidney cancer	0.000147	0.0014	CcSEcCtD
Zileuton—Vomiting—Gemcitabine—kidney cancer	0.000143	0.00136	CcSEcCtD
Zileuton—Rash—Gemcitabine—kidney cancer	0.000142	0.00135	CcSEcCtD
Zileuton—Dermatitis—Gemcitabine—kidney cancer	0.000142	0.00135	CcSEcCtD
Zileuton—Headache—Gemcitabine—kidney cancer	0.000141	0.00134	CcSEcCtD
Zileuton—Nausea—Vincristine—kidney cancer	0.000141	0.00134	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000141	0.00134	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—kidney cancer	0.000141	0.00134	CcSEcCtD
Zileuton—Insomnia—Capecitabine—kidney cancer	0.00014	0.00133	CcSEcCtD
Zileuton—Hypersensitivity—Paclitaxel—kidney cancer	0.000139	0.00132	CcSEcCtD
Zileuton—Dyspepsia—Capecitabine—kidney cancer	0.000136	0.0013	CcSEcCtD
Zileuton—Nausea—Gemcitabine—kidney cancer	0.000134	0.00127	CcSEcCtD
Zileuton—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000134	0.00127	CcSEcCtD
Zileuton—Pruritus—Paclitaxel—kidney cancer	0.000134	0.00127	CcSEcCtD
Zileuton—Constipation—Capecitabine—kidney cancer	0.000132	0.00126	CcSEcCtD
Zileuton—Pain—Capecitabine—kidney cancer	0.000132	0.00126	CcSEcCtD
Zileuton—Diarrhoea—Paclitaxel—kidney cancer	0.000129	0.00123	CcSEcCtD
Zileuton—Feeling abnormal—Capecitabine—kidney cancer	0.000128	0.00122	CcSEcCtD
Zileuton—Dizziness—Paclitaxel—kidney cancer	0.000125	0.00119	CcSEcCtD
Zileuton—Urticaria—Capecitabine—kidney cancer	0.000123	0.00117	CcSEcCtD
Zileuton—Body temperature increased—Capecitabine—kidney cancer	0.000122	0.00117	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—kidney cancer	0.000121	0.00115	CcSEcCtD
Zileuton—Tension—Doxorubicin—kidney cancer	0.00012	0.00114	CcSEcCtD
Zileuton—Vomiting—Paclitaxel—kidney cancer	0.00012	0.00114	CcSEcCtD
Zileuton—Rash—Paclitaxel—kidney cancer	0.000119	0.00113	CcSEcCtD
Zileuton—Dermatitis—Paclitaxel—kidney cancer	0.000119	0.00113	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—kidney cancer	0.000119	0.00113	CcSEcCtD
Zileuton—Headache—Paclitaxel—kidney cancer	0.000118	0.00113	CcSEcCtD
Zileuton—Hypersensitivity—Capecitabine—kidney cancer	0.000114	0.00109	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—kidney cancer	0.000114	0.00108	CcSEcCtD
Zileuton—Nausea—Paclitaxel—kidney cancer	0.000112	0.00107	CcSEcCtD
Zileuton—Malaise—Doxorubicin—kidney cancer	0.00011	0.00105	CcSEcCtD
Zileuton—Pruritus—Capecitabine—kidney cancer	0.00011	0.00104	CcSEcCtD
Zileuton—Diarrhoea—Capecitabine—kidney cancer	0.000106	0.00101	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—kidney cancer	0.000104	0.000991	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—kidney cancer	0.000104	0.000991	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—kidney cancer	0.000104	0.000991	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—kidney cancer	0.000103	0.00098	CcSEcCtD
Zileuton—Dizziness—Capecitabine—kidney cancer	0.000102	0.000975	CcSEcCtD
Zileuton—Vomiting—Capecitabine—kidney cancer	9.85e-05	0.000937	CcSEcCtD
Zileuton—Rash—Capecitabine—kidney cancer	9.77e-05	0.00093	CcSEcCtD
Zileuton—Dermatitis—Capecitabine—kidney cancer	9.76e-05	0.000929	CcSEcCtD
Zileuton—Headache—Capecitabine—kidney cancer	9.7e-05	0.000924	CcSEcCtD
Zileuton—Nausea—Capecitabine—kidney cancer	9.2e-05	0.000876	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.1e-05	0.000866	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—kidney cancer	9.03e-05	0.00086	CcSEcCtD
Zileuton—Somnolence—Doxorubicin—kidney cancer	8.88e-05	0.000845	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—kidney cancer	8.79e-05	0.000837	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.62e-05	0.000821	CcSEcCtD
Zileuton—Constipation—Doxorubicin—kidney cancer	8.54e-05	0.000813	CcSEcCtD
Zileuton—Pain—Doxorubicin—kidney cancer	8.54e-05	0.000813	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—kidney cancer	8.23e-05	0.000783	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—kidney cancer	7.93e-05	0.000755	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—kidney cancer	7.89e-05	0.000751	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—kidney cancer	7.36e-05	0.0007	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—kidney cancer	7.06e-05	0.000672	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—kidney cancer	6.83e-05	0.00065	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—kidney cancer	6.6e-05	0.000628	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—kidney cancer	6.35e-05	0.000604	CcSEcCtD
Zileuton—Rash—Doxorubicin—kidney cancer	6.3e-05	0.000599	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—kidney cancer	6.29e-05	0.000599	CcSEcCtD
Zileuton—Headache—Doxorubicin—kidney cancer	6.25e-05	0.000595	CcSEcCtD
Zileuton—Nausea—Doxorubicin—kidney cancer	5.93e-05	0.000565	CcSEcCtD
Zileuton—ALOX5—Metabolism—SLC5A5—kidney cancer	3.15e-05	0.000547	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	3.12e-05	0.000541	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—LDHB—kidney cancer	3.12e-05	0.000541	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—GSTM1—kidney cancer	3.11e-05	0.000539	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.11e-05	0.000539	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—kidney cancer	3.1e-05	0.000538	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	3.07e-05	0.000532	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	3.05e-05	0.000529	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—SLC2A1—kidney cancer	3.05e-05	0.000528	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.02e-05	0.000523	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GPC3—kidney cancer	2.99e-05	0.000518	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—POMC—kidney cancer	2.97e-05	0.000514	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HIF1A—kidney cancer	2.96e-05	0.000513	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.96e-05	0.000512	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TSC2—kidney cancer	2.95e-05	0.000511	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.95e-05	0.000511	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.91e-05	0.000504	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CA2—kidney cancer	2.91e-05	0.000504	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GSTP1—kidney cancer	2.89e-05	0.000502	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.88e-05	0.0005	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.85e-05	0.000495	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALAD—kidney cancer	2.83e-05	0.000491	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KDR—kidney cancer	2.83e-05	0.00049	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ST3GAL2—kidney cancer	2.77e-05	0.00048	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.73e-05	0.000473	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALDH1A1—kidney cancer	2.7e-05	0.000469	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CA9—kidney cancer	2.7e-05	0.000469	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.66e-05	0.000461	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.64e-05	0.000458	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.62e-05	0.000455	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—APC—kidney cancer	2.61e-05	0.000452	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KIT—kidney cancer	2.61e-05	0.000452	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ACY1—kidney cancer	2.59e-05	0.00045	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PGK1—kidney cancer	2.59e-05	0.000449	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SLC5A3—kidney cancer	2.59e-05	0.000449	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.58e-05	0.000447	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—LDHB—kidney cancer	2.54e-05	0.000441	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSTP1—kidney cancer	2.54e-05	0.00044	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.52e-05	0.000437	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—MAPK3—kidney cancer	2.5e-05	0.000433	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.49e-05	0.000431	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—POMC—kidney cancer	2.48e-05	0.00043	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—BRAF—kidney cancer	2.45e-05	0.000425	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ABCB1—kidney cancer	2.4e-05	0.000417	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—MAPK1—kidney cancer	2.37e-05	0.000412	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS2—kidney cancer	2.37e-05	0.00041	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSTM1—kidney cancer	2.33e-05	0.000405	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CRABP1—kidney cancer	2.3e-05	0.000399	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CA—kidney cancer	2.27e-05	0.000393	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—KRAS—kidney cancer	2.24e-05	0.000389	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.23e-05	0.000387	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ACY1—kidney cancer	2.22e-05	0.000384	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP1A1—kidney cancer	2.21e-05	0.000384	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.21e-05	0.000384	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PDHB—kidney cancer	2.21e-05	0.000382	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CA9—kidney cancer	2.2e-05	0.000382	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.2e-05	0.000382	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—POMC—kidney cancer	2.2e-05	0.000381	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.15e-05	0.000374	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ITPR2—kidney cancer	2.14e-05	0.000371	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CCBL1—kidney cancer	2.07e-05	0.00036	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTEN—kidney cancer	2.06e-05	0.000358	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CA—kidney cancer	2.06e-05	0.000357	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.05e-05	0.000356	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RAF1—kidney cancer	2.05e-05	0.000354	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RELA—kidney cancer	2.04e-05	0.000353	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.02e-05	0.000351	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ERBB2—kidney cancer	2.02e-05	0.000351	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MTOR—kidney cancer	2e-05	0.000346	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.97e-05	0.000342	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ACHE—kidney cancer	1.95e-05	0.000338	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTT1—kidney cancer	1.95e-05	0.000338	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.95e-05	0.000337	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.92e-05	0.000333	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.89e-05	0.000328	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PDHB—kidney cancer	1.89e-05	0.000327	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—POMC—kidney cancer	1.88e-05	0.000326	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.88e-05	0.000325	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CRABP1—kidney cancer	1.87e-05	0.000325	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CDKN1B—kidney cancer	1.87e-05	0.000325	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SCARB1—kidney cancer	1.85e-05	0.00032	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—kidney cancer	1.83e-05	0.000318	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS1—kidney cancer	1.83e-05	0.000317	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.82e-05	0.000315	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.8e-05	0.000312	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPAT—kidney cancer	1.8e-05	0.000312	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PSMD7—kidney cancer	1.79e-05	0.000311	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCND1—kidney cancer	1.79e-05	0.00031	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—JUN—kidney cancer	1.78e-05	0.000309	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.78e-05	0.000308	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CCBL1—kidney cancer	1.77e-05	0.000307	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CTNNB1—kidney cancer	1.77e-05	0.000307	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.76e-05	0.000305	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ITPR2—kidney cancer	1.74e-05	0.000302	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTEN—kidney cancer	1.73e-05	0.000299	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ACY1—kidney cancer	1.71e-05	0.000297	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—BCHE—kidney cancer	1.7e-05	0.000294	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SLC5A5—kidney cancer	1.68e-05	0.000291	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APRT—kidney cancer	1.67e-05	0.00029	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—FH—kidney cancer	1.67e-05	0.00029	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—POMC—kidney cancer	1.65e-05	0.000286	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.63e-05	0.000283	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SLC2A1—kidney cancer	1.62e-05	0.000281	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.61e-05	0.000278	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.6e-05	0.000278	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTT1—kidney cancer	1.59e-05	0.000275	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ACHE—kidney cancer	1.59e-05	0.000275	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GPC3—kidney cancer	1.57e-05	0.000273	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.57e-05	0.000272	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—kidney cancer	1.56e-05	0.00027	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPAT—kidney cancer	1.54e-05	0.000266	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.54e-05	0.000266	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CA2—kidney cancer	1.53e-05	0.000265	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.52e-05	0.000263	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SCARB1—kidney cancer	1.5e-05	0.000261	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.5e-05	0.00026	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALAD—kidney cancer	1.49e-05	0.000258	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK3—kidney cancer	1.47e-05	0.000256	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PSMD7—kidney cancer	1.46e-05	0.000253	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CA—kidney cancer	1.46e-05	0.000252	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PDHB—kidney cancer	1.46e-05	0.000252	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.45e-05	0.000252	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—POMC—kidney cancer	1.45e-05	0.000251	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MYC—kidney cancer	1.43e-05	0.000249	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APRT—kidney cancer	1.43e-05	0.000248	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—FH—kidney cancer	1.43e-05	0.000248	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.42e-05	0.000246	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK1—kidney cancer	1.4e-05	0.000243	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.4e-05	0.000242	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—BCHE—kidney cancer	1.38e-05	0.00024	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.37e-05	0.000238	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CCBL1—kidney cancer	1.37e-05	0.000237	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SLC5A5—kidney cancer	1.37e-05	0.000237	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.36e-05	0.000236	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PGK1—kidney cancer	1.36e-05	0.000236	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTP1—kidney cancer	1.35e-05	0.000234	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPC3—kidney cancer	1.34e-05	0.000233	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—LDHB—kidney cancer	1.34e-05	0.000232	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KRAS—kidney cancer	1.32e-05	0.00023	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SLC2A1—kidney cancer	1.32e-05	0.000229	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—kidney cancer	1.32e-05	0.000228	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CA2—kidney cancer	1.31e-05	0.000227	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.28e-05	0.000222	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ABCB1—kidney cancer	1.28e-05	0.000222	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALAD—kidney cancer	1.27e-05	0.000221	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.24e-05	0.000215	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTM1—kidney cancer	1.24e-05	0.000215	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CA—kidney cancer	1.22e-05	0.000211	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.21e-05	0.000211	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.19e-05	0.000206	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPAT—kidney cancer	1.19e-05	0.000206	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—kidney cancer	1.18e-05	0.000204	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP1A1—kidney cancer	1.18e-05	0.000204	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PGK1—kidney cancer	1.16e-05	0.000202	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.16e-05	0.000202	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CA9—kidney cancer	1.16e-05	0.000201	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTEN—kidney cancer	1.15e-05	0.000199	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—LDHB—kidney cancer	1.14e-05	0.000198	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.13e-05	0.000196	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.12e-05	0.000194	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—FH—kidney cancer	1.1e-05	0.000191	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APRT—kidney cancer	1.1e-05	0.000191	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTP1—kidney cancer	1.1e-05	0.000191	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ABCB1—kidney cancer	1.04e-05	0.000181	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPC3—kidney cancer	1.04e-05	0.00018	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTM1—kidney cancer	1.01e-05	0.000175	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CA2—kidney cancer	1.01e-05	0.000175	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CA9—kidney cancer	9.9e-06	0.000172	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CRABP1—kidney cancer	9.85e-06	0.000171	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALAD—kidney cancer	9.83e-06	0.00017	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.68e-06	0.000168	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.67e-06	0.000168	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP1A1—kidney cancer	9.6e-06	0.000166	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.59e-06	0.000166	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.38e-06	0.000163	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ITPR2—kidney cancer	9.16e-06	0.000159	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PGK1—kidney cancer	8.99e-06	0.000156	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.99e-06	0.000156	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LDHB—kidney cancer	8.82e-06	0.000153	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—POMC—kidney cancer	8.78e-06	0.000152	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.45e-06	0.000146	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CRABP1—kidney cancer	8.42e-06	0.000146	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ACHE—kidney cancer	8.35e-06	0.000145	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTT1—kidney cancer	8.35e-06	0.000145	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—kidney cancer	8.1e-06	0.00014	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SCARB1—kidney cancer	7.91e-06	0.000137	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.88e-06	0.000137	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ITPR2—kidney cancer	7.83e-06	0.000136	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS1—kidney cancer	7.83e-06	0.000136	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PSMD7—kidney cancer	7.68e-06	0.000133	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CA9—kidney cancer	7.64e-06	0.000132	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—BCHE—kidney cancer	7.28e-06	0.000126	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.22e-06	0.000125	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC5A5—kidney cancer	7.19e-06	0.000125	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—POMC—kidney cancer	7.16e-06	0.000124	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ACHE—kidney cancer	7.14e-06	0.000124	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTT1—kidney cancer	7.14e-06	0.000124	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—kidney cancer	7e-06	0.000121	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.94e-06	0.00012	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SCARB1—kidney cancer	6.76e-06	0.000117	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.74e-06	0.000117	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS1—kidney cancer	6.69e-06	0.000116	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PSMD7—kidney cancer	6.56e-06	0.000114	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CRABP1—kidney cancer	6.5e-06	0.000113	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—BCHE—kidney cancer	6.22e-06	0.000108	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC5A5—kidney cancer	6.14e-06	0.000106	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—kidney cancer	6.11e-06	0.000106	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ITPR2—kidney cancer	6.04e-06	0.000105	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.93e-06	0.000103	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.88e-06	0.000102	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTP1—kidney cancer	5.79e-06	0.0001	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.76e-06	9.98e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—kidney cancer	5.71e-06	9.89e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTT1—kidney cancer	5.51e-06	9.55e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ACHE—kidney cancer	5.51e-06	9.55e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCB1—kidney cancer	5.48e-06	9.5e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTM1—kidney cancer	5.32e-06	9.22e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SCARB1—kidney cancer	5.22e-06	9.04e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS1—kidney cancer	5.16e-06	8.95e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PSMD7—kidney cancer	5.06e-06	8.78e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.04e-06	8.74e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.02e-06	8.7e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—kidney cancer	4.98e-06	8.63e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTP1—kidney cancer	4.95e-06	8.58e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BCHE—kidney cancer	4.8e-06	8.32e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.74e-06	8.22e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCB1—kidney cancer	4.68e-06	8.12e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.58e-06	7.94e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTM1—kidney cancer	4.55e-06	7.88e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.31e-06	7.47e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—kidney cancer	4.31e-06	7.47e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.14e-06	7.18e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTP1—kidney cancer	3.82e-06	6.62e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—POMC—kidney cancer	3.76e-06	6.52e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCB1—kidney cancer	3.62e-06	6.27e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.54e-06	6.14e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—kidney cancer	3.51e-06	6.09e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTM1—kidney cancer	3.51e-06	6.08e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.33e-06	5.77e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—POMC—kidney cancer	3.21e-06	5.57e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—kidney cancer	3e-06	5.2e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—kidney cancer	2.62e-06	4.54e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—kidney cancer	2.56e-06	4.44e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—POMC—kidney cancer	2.48e-06	4.3e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—kidney cancer	2.24e-06	3.88e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—kidney cancer	1.98e-06	3.43e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.85e-06	3.2e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—kidney cancer	1.73e-06	2.99e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.58e-06	2.73e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.22e-06	2.11e-05	CbGpPWpGaD
